TNFSF11 and psoriatic arthritis: Finally, the study involving RANKL, a potent activator of bone reabsorption which is increased via IL-33, suggests a link between psoriatic cutaneous inflammation and the pathogenesis of psoriatic arthritis (PsA), thus explaining why, in most cases, Pso anticipates several decays the onset of PsA [18].